A detailed history of Van Hulzen Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 71,901 shares of NVO stock, worth $6.28 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
71,901
Previous 71,890 0.02%
Holding current value
$6.28 Million
Previous $10.3 Million 16.58%
% of portfolio
0.62%
Previous 0.69%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $1,309 - $1,599
11 Added 0.02%
71,901 $8.56 Million
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $9,189 - $12,232
90 Added 0.13%
71,890 $9.23 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $3.23 Million - $7.08 Million
35,473 Added 97.65%
71,800 $6.53 Million
Q2 2023

Aug 03, 2023

SELL
$155.98 - $172.65 $42,582 - $47,133
-273 Reduced 0.75%
36,327 $5.88 Million
Q1 2023

Apr 28, 2023

BUY
$132.34 - $159.14 $4.84 Million - $5.82 Million
36,600 New
36,600 $5.83 Million
Q4 2021

Feb 04, 2022

SELL
$95.88 - $117.08 $139,026 - $169,766
-1,450 Reduced 3.81%
36,600 $4.1 Million
Q2 2020

Aug 11, 2020

SELL
$58.54 - $67.94 $29,270 - $33,970
-500 Reduced 1.3%
38,050 $2.49 Million
Q2 2019

Aug 08, 2019

SELL
$46.79 - $52.47 $37,432 - $41,976
-800 Reduced 2.03%
38,550 $1.97 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $37,408 - $40,992
800 Added 2.08%
39,350 $1.86 Million
Q4 2017

Feb 12, 2018

BUY
$47.53 - $53.73 $97,436 - $110,146
2,050 Added 5.62%
38,550 $2.07 Million
Q2 2017

Aug 14, 2017

BUY
N/A
36,500
36,500 $1.57 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Van Hulzen Asset Management, LLC Portfolio

Follow Van Hulzen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.